Will brain cells derived from induced pluripotent stem cells or directly converted from somatic cells (iNs) be useful for schizophrenia research?

Schizophrenia Bulletin

Volumn 39, Issue 5, 2013, Pages 948-954

  Filippich, Cheryl ^a,b   Wolvetang, Ernst J ^a   Mowry, Bryan J ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

Author keywords

brain cells; experimental design; induced pluripotent stem cells; model; schizophrenia

Indexed keywords

DOPAMINE; GLUTAMIC ACID; IONOTROPIC RECEPTOR; N METHYL D ASPARTATE GLUTAMATE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BRAIN CELL; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REPRODUCIBILITY; SCHIZOPHRENIA; SEX DIFFERENCE; SOMATIC CELL; TECHNOLOGY;

BRAIN CELLS; EXPERIMENTAL DESIGN; INDUCED PLURIPOTENT STEM CELLS; MODEL; SCHIZOPHRENIA;

BIOMEDICAL RESEARCH; BRAIN; HUMANS; INDUCED PLURIPOTENT STEM CELLS; SCHIZOPHRENIA;

EID: 84883483235     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt103     Document Type: Article

References (65)

1. Brennand KJ, Gage FH. Modeling psychiatric disorders through reprogramming. Dis Model Mech. 2012;5:26-32
2. Clowry G, Molnár Z, Rakic P. Renewed focus on the developing human neocortex. J Anat. 2010;217:276-288
3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676
4. González F, Boué S, Izpisúa Belmonte JC. Methods for making induced pluripotent stem cells: Reprogramming à la carte. Nat Rev Genet. 2011;12:231-242
5. Swistowski A, Peng J, Liu Q, et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells. 2010;28:1893-1904
6. Pang ZP, Yang N, Vierbuchen T, et al. Induction of human neuronal cells by defined transcription factors. Nature. 2011;476:220-223
7. Wang LH, Wang LL, Huang WH, et al. Generation of integration- free neural progenitor cells from cells in human urine. Nature methods. 2013;10:84-U124
8. Karayiorgou M, Flint J, Gogos JA, Malenka RC; Genetic and Neural Complexity in Psychiatry 2011 Working Group. The best of times, the worst of times for psychiatric disease. Nat Neurosci. 2012;15:811-812
9. Mowry BJ, Gratten J. The emerging spectrum of allelic variation in schizophrenia: Current evidence and strategies for the identification and functional characterization of common and rare variants. Mol Psychiatry. 2013;18:38-52
10. Dolmetsch R, Geschwind DH. The human brain in a dish: The promise of iPSC-derived neurons. Cell. 2011;145:831-834
11. Chiang CH, Su Y, Wen Z, et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry. 2011;16:358-360
12. Brennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473:221-225
13. Pedrosa E, Sandler V, Shah A, et al. Development of patientspecific neurons in schizophrenia using induced pluripotent stem cells. J Neurogenet. 2011;25:88-103
14. Paulsen BD, Maciel RD, Galina A, et al. Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant. 2011
15. Vitale AM, Matigian NA, Ravishankar S, et al. Variability in the generation of induced pluripotent stem cells: Importance for disease modeling. Stem Cells Transl Med. 2012;1: 641-650
16. Robicsek O, Karry R, Petit I, et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry. 2013
17. Garcia I, Kim C, Arenkiel BR. Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons. Front Cell Neurosci. 2012;6:59
18. Panopoulos AD, Ruiz S, Izpisua Belmonte JC. iPSCs: Induced back to controversy. Cell Stem Cell. 2011;8:347-348
19. Abyzov A, Mariani J, Palejev D, et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature. 2012;492:438-442
20. Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell. 2008;3:595-605
21. Wells CA, Mosbergen R, Korn O, et al. Stemformatics: Visualisation and sharing of stem cell gene expression. Stem Cell Res. 2013;10:387-395
22. Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: The new patient? Nat Rev Mol Cell Biol. 2012;13:713-726
23. Zeng L, Zhang P, Shi L, Yamamoto V, Lu W, Wang K. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models. PLoS One. 2013;8:e59685
24. Kirov G, Rujescu D, Ingason A, Collier DA, O'Donovan MC, Owen MJ. Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull. 2009;35:851-854
25. Ching MS, Shen Y, Tan WH, et al.; Children's Hospital Boston Genotype Phenotype Study Group. Deletions of NRXN1) neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:937-947
26. Tchieu J, Kuoy E, Chin MH, et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell. 2010;7:329-342
27. Feng J, Sun G, Yan J, et al. Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS One. 2009;4:e6121
28. Piton A, Gauthier J, Hamdan FF, et al. Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry. 2011;16:867-880
29. Lin M, Pedrosa E, Shah A, et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One. 2011;6:e23356
30. Tran NN, Ladran IG, Brennand KJ. Modeling schizophrenia using induced pluripotent stem cell-derived and fibroblastinduced neurons. Schizophr Bull. 2013;39:4-10
31. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324:797-801
32. Hussein SM, Nagy K, Nagy A. Human induced pluripotent stem cells: The past, present, and future. Clin Pharmacol Ther. 2011;89:741-745
33. Somers A, Jean JC, Sommer CA, et al. Generation of transgenefree lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells. 2010;28:1728-1740
34. Yusa K, Rad R, Takeda J, Bradley A. Generation of transgenefree induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods. 2009;6:363-369
35. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009;4:381-384
36. Miyoshi N, Ishii H, Nagano H, et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell. 2011;8:633-638
37. Warren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7:618-630
38. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:348-362
39. Zhou T, Benda C, Duzinger S, et al. Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol. 2011;22:1221-1228
40. Doege CA, Inoue K, Yamashita T, et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature. 2012;488:652-655
41. Baumann K. Stem cells: Holding onto the memories. Nat Rev Genet. 2010;11:593
42. Briggs JA, Mason EA, Ovchinnikov DA, Wells CA, Wolvetang EJ. Concise review: New paradigms for Down syndrome research using induced pluripotent stem cells: Tackling complex human genetic disease. Stem Cells Transl Med. 2013;2:175-184
43. Rajesh D, Dickerson SJ, Yu J, Brown ME, Thomson JA, Seay NJ. Human lymphoblastoid B-cell lines reprogrammed to EBVfree induced pluripotent stem cells. Blood. 2011;118:1797-1800
44. Jiang H, Ren Y, Yuen EY, et al. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun. 2012;3:668
45. Yan Y, Yang D, Zarnowska ED, et al. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells. 2005;23:781-790
46. Bibel M, Richter J, Schrenk K, et al. Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci. 2004;7:1003-1009
47. Farra N, Zhang WB, Pasceri P, Eubanks JH, Salter MW, Ellis J. Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol Psychiatry. 2012;17:1261-1271
48. Mariani J, Simonini MV, Palejev D, et al. Modeling human cortical development in vitro using induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109:12770-12775
49. Czepiel M, Balasubramaniyan V, Schaafsma W, et al. Differentiation of induced pluripotent stem cells into functional oligodendrocytes. Glia. 2011;59:882-892
50. Juopperi TA, Kim WR, Chiang CH, et al. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Mol Brain. 2012;5:17
51. Arber C, Li M. Cortical interneurons from human pluripotent stem cells: Prospects for neurological and psychiatric disease. Front Cell Neurosci. 2013;7:10
52. Karumbayaram S, Novitch BG, Patterson M, et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells. 2009;27:806-811
53. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463:1035-1041
54. Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: Update 2012. Mol Psychiatry. 2012;17:1228-1238
55. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: Version III-The final common pathway. Schizophr Bull. 2009;35:549-562
56. Moghaddam B, Javitt D. From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37:4-15
57. Lindsley CW, Shipe WD, Wolkenberg SE, et al. Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr Top Med Chem. 2006;6:771-785
58. Jones AL, Mowry BJ, Pender MP, Greer JM. Immune dysregulation and self-reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol. 2005;83:9-17
59. Espuny-Camacho I, Michelsen KA, Gall D, et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron. 2013;77:440-456
60. Fish KN, Sweet RA, Lewis DA. Differential distribution of proteins regulating GABA synthesis and reuptake in axon boutons of subpopulations of cortical interneurons. Cereb Cortex. 2011;21:2450-2460
61. Jaaro-Peled H. Gene models of schizophrenia: DISC1 mouse models. Prog Brain Res. 2009;179:75-86
62. Zwijnenburg PJ, Meijers-Heijboer H, Boomsma DI. Identical but not the same: The value of discordant monozygotic twins in genetic research. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:1134-1149
63. Kinney DK, Hintz K, Shearer EM, et al. A unifying hypothesis of schizophrenia: Abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Med Hypotheses. 2010;74:555-563
64. Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013;70:271-278
65. Panchision DM. Meeting report: Using stem cells for biological and therapeutics discovery in mental illness, April 2012. Stem Cells Transl Med. 2013;2:217-222